PUBLICATIONS

Publications

  1. R Fatima, M Ul Haq, AYaqoob, N Mahmood, M Osberg, J Makayova, A Hymoff, and Christy Hanson. Delivering Patient-Centered Care in a Fragile State: Using Patient-Pathway Analysis to Understand TuberculosisRelated Care Seeking in Pakistan. The Journal of Infectious diseases Supplement article JID 2017:216 (Suppl 7) • S733;7th November 2017. Cited: 4 , Impact factor: 5.19
  2. Fatima R, Harris RJ, Enarson DA, Hinderaker SG, Qadeer E, Ali K, Bassilli A. Estimating tuberculosis burden and case detection in Pakistan. The International Journal of Tuberculosis and Lung Disease. 2014 Jan 1;18(1):55-60. Cited: 37  , Impact factor: 2.76
  3. R. Fatima, E. Qadeer, D. A. Enarson, J. Creswell, R. Stevens, S. G. Hinderaker, M. ul Haq: Success of active tuberculosis case detection among high-risk groups in urban slums in Pakistan. The International Journal of Tuberculosis and Lung Disease 09/2014; 18(9). Cited: 15  , Impact factor:
  4. Fatima R, Qadeer E, Yaqoob A, ul Haq M, Majumdar SS, Shewade HD, Stevens R, Creswell J, Mahmood N, Kumar AM. Extending ‘Contact Tracing’into the Community within a 50-Metre Radius of an Index Tuberculosis Patient Using Xpert MTB/RIF in Urban, Pakistan: Did It Increase Case Detection?. PloS one. 2016 Nov 29;11(11). Cited:6, Impact factor: 2.76
  5. Bassili A, Fitzpatrick C, Qadeer E, Fatima R, Floyd K, Jaramillo E. A systematic review of the effectiveness of hospital-and ambulatory-based management of multidrug-resistant tuberculosis. The American journal of tropical medicine and hygiene. 2013 Aug 7;89(2):271-80. Cited: 61  , Impact factor: 2.56
  6. Fatima R, Qadeer E, Enarson DA, Hinderaker SG, Harris R, Yaqoob A, Bassili A. Investigation of presumptive tuberculosis cases by private health providers: lessons learnt from a survey in Pakistan. Public health action. 2014 Jun 21;4(2):110-2. Cited: 5 , Impact factor: 2.76
  7. Qadeer E, Fatima R, Yaqoob A, Tahseen S, Haq MU, Ghafoor A, Asif M, Straetemans M, Tiemersma EW. Population based national tuberculosis prevalence survey among adults (> 15 years) in Pakistan, 2010–2011. PloS one. 2016 Feb 10;11(2). Cited: 22  , Impact factor: 2.76
  8. Qadeer E, Fatima R, Fielding K, Qazi F, Moore D, Khan MS. Good quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosis. PloS one. 2015 Apr 29;10(4). Cited: 5 , Impact factor: 2.76
  9. Fatima R, Qadeer E, Hinderaker SG, Yaqoob A, Enarson DA, Bassili A, Javed B. Can the number of patients with presumptive tuberculosis lost in the general health services in Pakistan be reduced?. The International Journal of Tuberculosis and Lung Disease. 2015 Jun 1;19(6):654-6. Cited: 8  , Impact factor: 2.76
  10. Hinderaker SG, Fatima R. Lost in time and space: the outcome of patients transferred out from large hospitals. Public health action. 2013 Mar 21;3(1):2. Cited: 1, Impact factor: 2.76
  11. Safdar N, Zahid R, Shah S, Fatima R, Cameron I, Siddiqi K. Tuberculosis patients learning about second-hand smoke (TBLASS): results of a pilot randomised controlled trial. The International Journal of Tuberculosis and Lung Disease. 2015 Feb 1;19(2):237-43. Cited: 2 , Impact factor: 2.76
  12. Safdar N, Zahid R, Shah S, Cameron I, Fatima R, Qureshi H, Siddiqi K. TB patients learning about second hand smoke (TBLASS): a pilot individual randomised controlled trial. SpringerPlus. 2013 Dec;2(1):556. Cited: 1, Impact factor: 2.5
  13. Fatima R, Ejaz Q, Enarson DA, Bissell K. Comprehensiveness of primary services in the care of infectious tuberculosis patients in Rawalpindi, Pakistan. Public Health Action. 2011 Sep 21;1(1):13-5. Cited: 14, Impact factor: 2.76
  14. Pirkani GS, Qadeer E, Ahmad N, Razia F, Khurshid Z, Khalil L, Shuib M, Naeem A. Impact of training of religious leaders about tuberculosis on case detection rate in Balochistan, Pakistan. Journal of the Pakistan Medical Association. 2006 Sep;1:114. Cited: 5  , Impact factor:0.46
  15. Ahmad G, Qadeer E, Ahmad N, Fatima R, Khursheed Z. Defaulting Rate of TB Patients among Seasonal Migrants (A Case Study of Balochistan). Journal of the Pakistan Medical Association. 2006 Sep;7:112.Cited: 0  , Impact factor: 0.46
  16. W.Aslam, S. Tahseen, C. Schomotzer, A. Hussain, F. Khanzada, M. ul Haq, N. Mahmood, R. Fatima, E. Qadeer EH. Gastric specimens for diagnosing tuberculosis in adults unable to expectorate in Rawalpindi, Pakistan. Public Heal action. 2017;7(2):242–146. Cited: 2, Impact factor: 2.76
  17. B. J. Khan, A. M. V. Kumar, A. Stewart, N. M. Khan, K. Selvaraj, R. Fatima ZS. Alarming rates of attrition among tuberculosis patients in public-private facilities in Lahore, Pakistan. Public Heal action. 2017;7(2):127–33. Cited: 3, Impact factor: 2.76
  18. Capileno YA, Van Den Bergh R, Donchunk D, Hinderaker SG, Hamid S, Auat R, et al. Management of chronic Hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan. PLoS One. 2017;12(4). Cited:13, Impact factor:2.76
  19. Waheed Y, Khan MA, Fatima R, Yaqoob A, Mirza A, Qadeer E, Shakeel M, Heldal E, Kumar AM. Infection control in hospitals managing drug-resistant tuberculosis in Pakistan: how are we doing?. Public health action. 2017 Mar 21;7(1):26-31. Cited: 6 , Impact factor: 2.76
  20. Khurshid A, Hinderaker SG, Heldal E, Fatima R, Haq M, Yaqoob A, Ansari A, Anwar K, Qadeer E, Kumar AM. Did “Screeners” Increase Pediatric Tuberculosis Case Notification in Sindh, Pakistan?. Journal of Tuberculosis Research. 2017 Feb 8;5(01):81. Cited: 2, Impact factor: 0.76
  21. Wali A, Kumar AM, Hinderaker SG, Heldal E, Qadeer E, Fatima R, Ullah A, Safdar N, Yaqoob A, Anwar K, Ul Haq M. Pre-treatment loss to follow-up among smear-positive TB patients in tertiary hospitals, Quetta, Pakistan. Public health action. 2017 Mar 21;7(1):21-5. Cited: 3 , Impact factor: 2.76
  22. Qadeer E, Fatima R, Haq MU, Yaqoob A, Kyaw NT, Shah S, Das M, Isaakidis P. Yield of facility-based verbal screening amongst household contacts of patients with multi-drug resistant tuberculosis in Pakistan. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2017 May 1;7:22-7. Cited: 0, Impact factor: 0.87
  23. Shakoor S, Tahseen S, Jabeen K, Fatima R, Malik FR, Rizvi AH, Hasan R. Fluoroquinolone consumption and-resistance trends in Mycobacterium tuberculosis and other respiratory pathogens: ecological antibiotic pressure and consequences in Pakistan, 2009–2015. International journal of mycobacteriology. 2016 Dec 1;5(4):412-6. Cited: 4, Impact factor: 0.40
  24. Latif A, Ghafoor A, Wali A, Fatima R, Yaqoob A, Abdullah Z, Najmi H, Khan NM. Did diabetes mellitus affect treatment outcome in drug-resistant tuberculosis patients in Pakistan from 2010 to 2014?. Public health action. 2018 Mar 21;8(1):14-9. Cited: 0, Impact factor: 2.76
  25. Contribution of Public Private Mix Models in TB Case Notification and Treatment Outcomes in Pakistan; 2015-16 submitted to IJTLD in Nov 2017 and in process
  26. Atif M, Bashir A, Ahmad N, Fatima RK, Saba S, Scahill S. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients. BMC infectious diseases. 2017 Dec;17(1):655. Cited: 0, Impact factor: 2.62
  27. Safdar MA, Fatima R, Khan NM, Yaqoob A, Khurshid A, Haq MU, Wali A. Prevalence of Human Immune Deficiency among Registered Tuberculosis Patients across Pakistan during 2013-2015—Prevalence of TB-HIV Co-Infection in Pakistan. Journal of Tuberculosis Research. 2018 Mar 6;6(01):96. Cited:0, Impact factor: 0.76
  28. Mirza AS, Fatima R, Yaqoob A, Qadeer E, Wali A, Khurshid A, Haq MU, Kumar AM. Enhancing Childhood TB Notifications by Strengthening Linkages with Large Hospitals in Pakistan—Childhood TB in Large Hospitals, Pakistan. Journal of Tuberculosis Research. 2018 Mar 6;6(01):63. Cited: 0  , Impact factor: 0.76
  29. Dogar O, Barua D, Boeckmann M, Elsey H, Fatima R, Gabe R, Huque R, Keding A, Khan A, Kotz D, Kralikova E. The safety, effectiveness and cost‐effectiveness of cytisine in achieving six‐month continuous smoking abstinence in tuberculosis patients—protocol for a double‐blind, placebo‐controlled randomized trial. Addiction. 2018 Sep;113(9):1716-26. Cited: 2, Impact factor: 5.78
  30. Ashraf R, Naureen F, Noor A, Ilyas J, Fatima R, Yaqoob A, Wali A, Haq MU, Latif A, Hussain S. Does Cash Incentive Effect TB Case Notification by Public Private Mix-General Practitioners Model in Pakistan?. Journal of Tuberculosis Research. 2018 May 9;6(02):166. Cited: 2, Impact factor: 0.76
  31. Najmi H, Ahmed H, Halepota GM, Fatima R, Yaqoob A, Latif A, Ahmad W, Khursheed A. Community-based integrated approach to changing women’s family planning behaviour in Pakistan, 2014–2016. Public health action. 2018 Jun 21;8(2):85-90. Cited: 0, Impact factor: 2.76
  32. Atif M, Anwar Z, Fatima RK, Malik I, Asghar S, Scahill S. Analysis of tuberculosis treatment outcomes among pulmonary tuberculosis patients in Bahawalpur, Pakistan. BMC research notes. 2018 Dec;11(1):370. Cited: 2, Impact factor: 2.62
  33. Sismanidis C, Glaziou P, Bloss E, van Hest R, Fatima R, Hoa NB, van den Werf M, Scott C, Colvin C, Abubakar11 I, Floyd K. Understanding and addressing the tuberculosis case detection gap: national inventory studies to improve estimates of incidence and strengthen surveillance. 2016
  34. oeckmann M, Nohavova I, Dogar O, Kralikova E, Pankova A, Zvolska K, Huque R, Fatima R, Noor M, Elsey H, Sheikh A. Protocol for the mixed-methods process and context evaluation of the TB & Tobacco randomised controlled trial in Bangladesh and Pakistan: a hybrid effectiveness–implementation study. BMJ open. 2018 Mar 1;8(3). Cited: 0, Impact factor: 2.41
  35. Fatima R, Yaqoob A, Qadeer E, Hinderaker SG, Heldal E, Zachariah R, Harries AD, Kumar AM. Building sustainable operational research capacity in Pakistan: starting with tuberculosis and expanding to other public health problems. Global Health Action. 2019 Jan 1;12(1). Cited: 0, Impact factor: 1.90
  36. Kurd SA, Wali A, Fatima R, Yaqoob A, Khan D, Lehri S. Pre-treatment loss to follow-up among patients with rifampicin-resistant tuberculosis in Baluchistan, Pakistan, 2012-17: a retrospective cohort study. F1000Research. 2018 Dec 7;7. Pubmed index
  37. Habib H, Fatima R, Achakzai AB, Wali A, Yaqoob A, Najmi H, Haq MU, Majeed A. Two parallel reporting systems for malaria surveillance in Pakistan, 2013–17: is exact burden reflected?. F1000Research. 2018 Dec 28;7. Pubmed index
  38. Hussain M, Fatima R, Qasim Z, Yaqoob A, Wali A, Abbasi S, Tahseen S. Is the public-private mix approach increasing tuberculosis case notification in Azad Jammu and Kashmir, Pakistan? A cross-sectional study. F1000Research. 2019 Jan 9;8. Pubmed index
  39. Khan MD, Wali A, Fatima R, Yaqoob A, Aziz S. Prevalence and associated risk factors of HIV in prisons in Balochistan, Pakistan: a cross-sectional study. F1000Research. 2018 Nov 20;7. Pubmed index
  40. Shah Z, Khan MA, Najmi H, Fatima R, Yaqoob A, Ghafoor A, et al. Assessment of Retreatment Tuberculosis Cases amongst All Tuberculosis Cases Notification in District Swat 2015-2017: A Retrospective Cohort Review. J Tuberc Res. Scientific Research Publishing; 2019 Jan 16;07(01):11–8. Recently published , Impact factor: 0.76
  41. Amyn A Malik, Junaid Fuad, Sara Siddiqui, Farhana Amanullah, Maria Jaswal, Zainab Barry PMDCP, Farhat Jabeen, Razia Fatima, Courtney M Yuen, Naseem Salahuddin, Aamir J Khan, Salmaan Keshavjee, Mercedes C Becerra, Hamidah Hussain, TB Preventive Therapy for individuals exposed to drug-resistant tuberculosis: feasibility and safety of a community-based delivery of fluoroquinolone-containing preventive regimen, Clinical Infectious Diseases, , ciz502
  42. Fatima RK. Peer Review Report For: Screening tuberculosis patients for diabetes mellitus in a routine program setting in Kampala, Uganda: a cross-sectional study [version 2; peer review: 2 approved]. F1000Research 2019, 8:872
  43. Razia Fatima, Aashifa Yaqoob, Kamran Siddiqi, Omara Dogar, Sarwat Shah, Aamer Ikram,Assessing Tuberculosis among Smokers: Secondary Analysis of an Active Case Finding Project January 2019 Journal of Tuberculosis Research 07(04):246-252
  44. Razia Fatima, Aashifa Yaqoob,,Ejaz Qadeer, Sven Gudmund Hinderaker,Aamer Ikram,Charalambos Sismanidis.Measuring and addressing the childhood tuberculosis reporting gaps in Pakistan: The first ever national inventory study among children.December 2019 PLoS ONE 14(12):e0227186 DOI:
  45. Wali A, Khan D, Safdar N, et al. Prevalence of tuberculosis, HIV/AIDS, and hepatitis; in a prison of Balochistan: a cross-sectional survey. BMC Public Health. 2019;19(1):1631. Published 2019 Dec 4. doi:10.1186/s12889-019-8011-7
  46. Fatima R, Yaqoob A. Strengthening and implementing operational research in National TB Programmes: the Global Fund’s vital role. The International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease. 2020 Feb 1;24(2):259-60.
  47. Ullah W, Almansour H, Fatima R, Saini B, Khan GM. Engaging Community Pharmacies in Early Detection of Missing Tuberculosis Patients through Public–Private Mix Intervention in Pakistan. The American Journal of Tropical Medicine and Hygiene. 2020 May 4:tpmd190939
  48. Van Gurp M, Rood E, Fatima R, Joshi P, Verma SC, Khan AH, et al. Finding gaps in TB notifications: spatial analysis of geographical patterns of TB notifications, associations with TB program efforts and social determinants of TB risk in Bangladesh, Nepal, and Pakistan. BMC Infect Dis [Internet]. 2020; 20(1):490.
  49. Atif, M., Fatima, R., Ahmad, N. et al. Treatment outcomes of extrapulmonary tuberculosis in Bahawalpur, Pakistan; a record review. J of Pharm Policy and Pract 13, 35 (2020).
  50. Omara Dogar, Ada Keding, Rhian Gabe, Anna-Marie Marshall, Rumana Huque, Deepa Barua, Razia Fatima, et al Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. LANGLH-D-20-00622
  51. Mishal Khan, Sonia Rego, Joaquin Benitez Rajal, Virginia Bond, Razia Kaneez Fatima, Afshan Khurshid Isani, Jayne Sutherland, Katharina Kranzer. Mitigating the impact of COVID-19 on tuberculosis and HIV services: a cross-sectional survey of 669 health professionals in 64 low and middle-income countries.
  52. Yaqoob, A., Hinderaker, S., Fatima, R., Najmi, H. and Haq, A. How do private practitioners in Pakistan manage children suspected having tuberculosis? A cross sectional study.
  53. Zumla A, Chakaya J, Khan M, Fatima R, Wejse C, Al-Abri S, Fox GJ, Nachega J, Kapata N, Knipper M, Orcutt M. World Tuberculosis Day 2021 Theme—‘The Clock is Ticking’—and the world is running out of time to deliver the United Nations General Assembly commitments to End TB due to the COVID-19 pandemic. International Journal of Infectious Diseases. 2021 Mar 18.
  54. Fatima R, Akhtar N, Yaqoob A, Harries AD, Khan MS. Building better tuberculosis control systems in a post-COVID world: learning from Pakistan during the COVID-19 pandemic. International Journal of Infectious Diseases. 2021 Mar 17.
  55. Chakaya J, Khan M, Ntoumi F, Aklillu E, Razia F, Mwaba P, Kapata N, Mfinanga S, Hasnain SE, Katoto PD, Bulabula AN. Global Tuberculosis Report 2020–Reflections on the Global TB burden, treatment and prevention efforts. International Journal of Infectious Diseases. 2021 Mar 11.
  56. Arif A, Ahmad E, Khan FN, Fatima R. A cohort study analyzing the impact of socioeconomic and spatial characteristics alongside treatment regimens on the environmental-health outcomes of the MDR-TB treatment in Pakistan. Environmental Science and Pollution Research. 2021 Mar 4:1-5
  57. Arif A, Ahmad E, Khan FN, Fatima R. Formal Education Vs Health Literacy: An Insight into Treatment Outcome of the Randomized Control Trial of MDR-TB Patients in Pakistan. Journal of Arts & Social Sciences (JASS). 2021 Jun 29;8(1):127-36.
  58. Hussain M, Fatima R, Baig MA, Masood N. Assessment of Tuberculosis case notification and percent change b/w public and private Tuberculosis health care facilities in Karachi, Pakistan-2016–17. International Journal of Infectious Diseases. 2020 Dec 1;101:357-8.
  59. Siddiqi K, Keding A, Marshall A, Dogar OF, Li J, Huque R, Fatima R, Khan A, Elsey H, Gabe R, Kotz D. Do smokers with tuberculosis who quit smoking during treatment have better health outcomes than those who don’t? A secondary analysis of the TB & Tobacco Trial. Thorax. 2021 Jun 25.
  60. Elsey H, Al Azdi Z, Regmi S, Baral S, Fatima R, Fieroze F, Huque R, Karki J, Khan DM, Khan A, Khan Z. Scaling up tobacco cessation within TB programmes: findings from a multi-country, mixed-methods implementation study. Health Research Policy and Systems. 2022 Dec;20(1):1-20.
  61. Fatima R, Yaqoob A, Qadeer E, Khan MA, Ghafoor A, Jamil B, Haq MU, Ahmed N, Baig S, Rehman A, Abbasi Q. Community-vs. hospital-based management of multidrug-resistant TB in Pakistan. The International Journal of Tuberculosis and Lung Disease. 2022 Oct 1;26(10):929-33.
  62. Haq MU, Hinderaker SG, Fatima R, Qadeer E, Habib H, Hussain K, Khan AW. Are patients with pulmonary tuberculosis identified by active and by passive case detection different? A cross-sectional study in Pakistan. Int J Infect Dis. 2022 Aug;121:39-46. doi: 10.1016/j.ijid.2022.04.055. Epub 2022 Apr 27. PMID: 35489633.
  63. Li J, Parrott S, Keding A, Dogar O, Gabe R, Marshall AM, Huque R, Barua D, Fatima R, Khan A, Zahid R, Mansoor S, Kotz D, Boeckmann M, Elsey H, Kralikova E, Readshaw A, Sheikh A, Siddiqi K; TB & Tobacco Consortium. Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly diagnosed pulmonary tuberculosis: an economic evaluation of a multicentre randomised controlled trial. BMJ Open. 2022 Aug 26;12(8):e049644. doi: 10.1136/bmjopen-2021-049644. PMID: 36028279; PMCID: PMC9422837.
  64. Yaqoob A, Alvi MR, Fatima R, Najmi H, Samad Z, Nisar N, Haq AU, Javed B, Khan AW, Hinderaker SG. Geographic accessibility to childhood tuberculosis care in Pakistan. Glob Health Action. 2022 Dec 31;15(1):2095782. doi: 10.1080/16549716.2022.2095782. PMID: 35848796; PMCID: PMC9297715.
  65. Aslam H, Omar A, Fatima R, Rasool U, Yaqoob A, Ullah W, Khan A, Khan YH, Mallhi TH. Treatment outcomes and adverse drug reactions among patients with drug–resistant tuberculosis receiving all-oral, long–term regimens: First record viewing report from Pakistan. Asian Pacific Journal of Tropical Medicine. 2023 Feb 1;16(2):58-64
  66. Jamil B, Nair D, Thekkur P, Laeeq N, Adil A, Khogali M, Zachariah R, Dar Berger S, Satyanarayana S, Kumar AM, Bochner A. Feasibility, enablers and challenges of using timeliness metrics for household contact tracing and TB preventive therapy in Pakistan. Plos one. 2023 Dec 11;18(12):e0295580.
  67. van den Boom M, Bennani K, Sismanidis C, Gunneberg C, Khawaja L, Safdar MA, Muhwa C, Heldal E, Cirillo DM, Khan AW, Fatima R. 2022 TB programme review in Pakistan: strengthening governance, with better patient diagnosis and treatment. IJTLD OPEN. 2024 Mar 1;1(3):136-43.
  68. Coussens AK, Zaidi SM, Allwood BW, Dewan PK, Gray G, Kohli M, Kredo T, Marais BJ, Marks GB, Martinez L, Ruhwald M. Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise. The Lancet Respiratory Medicine. 2024 Mar 22.
  69. Schwalb A, Samad Z, Yaqoob A, Fatima R, Houben RM. Subnational tuberculosis burden estimation for Pakistan. PLOS Global Public Health. 2024 Sep 23;4(9):e0003653
  70. Kirubi, Beatrice, et al. “Enhancing tuberculosis case notifications through mapping sales of medicine in the private sector: A quasi-experimental study in Punjab Province, Pakistan.” (2024).